Regulatory aspects of myogenic factors GDF-8 and Follistatin on the intake of combined oral contraceptives
Other
OA: closed
CC0
AI-generated summary
Women using combined oral contraceptives exhibited decreased GDF-8 and increased Follistatin levels, while in vitro exposure to contraceptive hormones induced a pro-myogenic effect on human skeletal muscle cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Combined oral contraceptives are one of the most prescribed drugs in the western world. While there is little evidence regarding effects of estrogen or gestagens on muscle metabolism, androgens are well-known for their anabolic characteristics. In this study, we seeked to investigate potential correlations of the myokines GDF-8, IGF-1 and Follistatin with female sexual hormones and likewise possible interactions with combined oral contraceptives (Dienogest and Ethyl Estradiol) intake. We obtained serum samples of young healthy women to measure hormone correlations. Furthermore, we simulated combined oral contraceptive blood circulating hormone concentrations to identify myogenic effects on HSkM in vitro. GDF-8, IGF-1 and Follistatin showed concentration correlations (p = .005) in overall patients' serum, while Follistatin as a promyogenic protein additionally showed a positive correlation with testosterone and estradiol (p < .05). Lower GDF-8 levels were also linked to a higher BMI (p = .009). Upon combined oral contraceptives (COC) intake, patients showed decreased GDF-8 (p = .006) but increased Follistatin (p = .0001) concentrations compared to patients without COC intake. In vitro, addition of Ethyl Estradiol and Dienogest to HSkM cells revealed a pro-myogenic, proliferative, chemosensitized pattern. Our data support a pro-myogenic effect of combined oral contraceptives.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (27)
- Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis via openalex
- doi:10.1016/j.bbrc.2009.12.123 via openalex
- doi:10.1111/acel.12174 via openalex
- doi:10.1038/sj.mt.6300182 via openalex
- doi:10.1586/erc.09.175 via openalex
- doi:10.1210/jcem.77.4.8408450 via openalex
- doi:10.1006/gcen.2000.7522 via openalex
- doi:10.1016/j.mce.2011.11.019 via openalex
- doi:10.1210/jc.2013-2835 via openalex
- doi:10.3109/09513590009167670 via openalex
- doi:10.1111/cen.13871 via openalex
- doi:10.1159/000500760 via openalex
- doi:10.1101/gr.7.9.910 via openalex
- doi:10.1177/1457496918812230 via openalex
- doi:10.1016/j.ejogrb.2018.11.015 via openalex
- doi:10.1038/s41598-017-10404-z via openalex
- doi:10.1093/humupd/dmq022 via openalex
- doi:10.1016/j.contraception.2010.04.006 via openalex
- doi:10.1210/jc.2010-3027 via openalex
- doi:10.1080/03014460151056437 via openalex
- doi:10.1016/0010-7824(80)90120-1 via openalex
- doi:10.1152/jappl.1989.66.1.498 via openalex
- doi:10.1007/978-3-540-37696-5_9 via openalex
- doi:10.1016/j.breast.2017.11.010 via openalex
- doi:10.1097/00000658-200104000-00012 via openalex
- doi:10.1016/b978-012369443-0/50067-3 via openalex
- doi:10.1016/j.bbrc.2015.07.018 via openalex
SciLite annotations
chemicals 8
estrogen
androgen
dienogest
ethyl octadecanoate
testosterone
estradiol
ethyl octadecanoate
dienogest
organisms 1
noordeloos 2009062
Source provenance
- openalex
- last seen: 2026-05-10T11:24:04.130763+00:00
- pubmed
- last seen: 2026-10-08T21:25:31.705136+00:00
- scilite
- last seen: 2026-05-18T04:26:01.642840+00:00
- unpaywall
- last seen: 2026-11-20T08:37:33.920708+00:00
License: CC0
· commercial use OK